 VistaGen Therapeutics, Inc. NASDAQ:VTGN Q4 2022 Earnings Conference Call June 23, 2022 5:00 PM ET Company Participants Mark Flather - Vice President of Investor Relations Shawn Singh - Chief Executive Officer Jerrold Dotson - Vice President, Chief Financial Officer and Secretary Mark Smith - Chief Medical Officer Conference Call Participants Andrew Tsai - Jefferies LLC Lachlan Hanbury-Brown - William Blair Company, LLC Luke Herrmann - Robert W. Baird Co. Michael Okunewitch - Maxim Group LLC Operator Greetings, welcome to the VistaGen Therapeutics 2022 Fiscal Year-End Results Conference Call. 